Omega-3 for skin — from dryness to inflammation

If you've tried every moisturiser on the shelf and your skin still feels dehydrated, reactive or inflamed, the missing piece may be inside-out rather than topical. Omega-3 EPA and DHA sit at the centre of skin membrane lipid biology and inflammatory signalling — two of the less-discussed but clinically important levers in skin quality.

Why omega-3 matters for skin

Your skin is not just a surface. Every cell membrane in it — and there are many — is built from fatty acids. The type of fatty acids you eat directly influences which fatty acids your cells incorporate into their membranes. Diets high in omega-6 and low in omega-3 produce membranes with more pro-inflammatory precursors; diets with an adequate omega-3 intake produce membranes with more of the anti-inflammatory resolvin and protectin precursors.

What this means visibly and functionally:

• Barrier quality — better lipid composition = better barrier = less transepidermal water loss = less dryness.
• Inflammatory tone — lower baseline inflammation = fewer flares in sensitive and reactive skin.
• Response to sun damage — omega-3 modulates some of the inflammatory cascades triggered by UV exposure.
• Acne context — diets low in omega-3 and high in refined sugars and ultra-processed fats associate with higher acne prevalence in observational data.

The EU authorised claim that most directly covers omega-3 is the heart function one at 250 mg EPA+DHA daily^[1]. Skin is not itself an authorised-claim category for omega-3, but skin physiology sits inside the broader lipid-and-inflammation biology that omega-3 reliably influences.

The specific skin contexts where omega-3 matters

Persistent dryness and tightness. If your skin feels dehydrated even with good topical moisturising, membrane lipid quality is often the missing piece. Omega-3 supplementation for 8–12 weeks shows measurable effects on skin hydration and trans-epidermal water loss in several clinical studies.

Eczema-type patterns. The research literature on omega-3 in atopic-dermatitis-type conditions is active. Not a treatment claim — atopic dermatitis is a medical condition that needs a dermatologist — but a pattern where inside-out nutrition often matters alongside topical care.

Rosacea-type sensitivity. Inflammation-prone skin tends to benefit from reducing the background inflammatory tone that diet contributes to.

Acne-prone adult skin. Not a magic fix, but omega-3 is one of the consistent dietary variables in acne research — high-omega-3, moderate-glycaemic-load diets show lower acne prevalence. A 12-week RCT in young men reported a low-glycaemic-load diet significantly reduced acne lesions and improved insulin sensitivity^[2].

Photoageing prevention. Omega-3 modulates some of the UV-triggered inflammatory responses that contribute to cumulative skin ageing.

The two forms of omega-3 that matter

Marine omega-3 (EPA + DHA). The bioactive forms. Found in oily fish (salmon, mackerel, sardines, herring, trout). NHS guidance is at least one portion of oily fish a week^[3]. Our Omega-3 fish oil delivers this in re-esterified triglyceride form — one of the higher-quality format choices, with low TOTOX (oxidation) values. A head-to-head bioavailability study reported rTG fish oil at 124% relative absorption versus natural fish oil, while ethyl ester sat at 73%^[4].

Algae-derived omega-3 (EPA + DHA). The same bioactive EPA and DHA, sourced from microalgae rather than through fish. The vegan-compatible route. Our life'sOMEGA algae oil uses the life'sOMEGA strain and clears the 250 mg threshold comfortably.

Plant-source ALA (flaxseed, walnuts, chia, rapeseed oil). The precursor form. The body converts ALA to EPA and DHA at low and variable rates — one well-cited isotope-tracer study in young women reported around 21% conversion to EPA and 9% to DHA^[5], and conversion is typically much lower in men. Not enough to meet adequate EPA+DHA status from plants alone. ALA does carry an authorised EU claim for contributing to maintenance of normal blood cholesterol levels at 2 g daily, but for skin-specific effects, EPA+DHA is the more relevant target.

For clarity: the skin-relevant dose target is at least 250 mg EPA+DHA daily (the authorised-claim threshold), with most clinical-skin research using 500–1000 mg daily.

Pairing omega-3 with the skin-specific nutrients

Omega-3 works best alongside the other inside-out skin nutrients:

• Vitamin A — contributes to maintenance of normal skin (authorised claim)^[1]. In our LipidCell alongside squalane and ceramides.
• Vitamin E — contributes to protection of cells from oxidative stress (authorised claim). Also in LipidCell.
• Vitamin C — contributes to normal collagen formation for the normal function of skin and protection of cells from oxidative stress (authorised claims).
• Zinc — contributes to maintenance of normal skin (authorised claim). Particularly relevant for acne-prone skin.
• Biotin — contributes to maintenance of normal skin and hair (authorised claim). In our B-Complex.
• Niacin (B3) and riboflavin (B2) — both contribute to maintenance of normal skin (authorised claims).

Our full skin nutrient map is in the beauty vitamins guide and the hydrolipid barrier guide.

Quality matters: what to look for in an omega-3

• EPA+DHA content on the label — not total fish oil. A 1000 mg fish-oil capsule may contain only 200 mg EPA+DHA.
• Form — re-esterified triglyceride (rTG) or natural triglyceride (nTG) are better-absorbed than ethyl ester (EE)^[4].
• Freshness / TOTOX number — the industry oxidation marker. Lower is better. Oxidised fish oil does the opposite of what you want for inflammatory tone.
• Third-party testing — IFOS or equivalent.
• Sustainability — MSC-certified sourcing for fish oil, or algae oil as the non-fish alternative.

Our Omega-3 fish oil is rTG form, IFOS-tested, MSC-sourced — the details are in our omega-3 selection guide.

The realistic skin-focused omega-3 protocol

1. Oily fish twice a week if tolerated — salmon, mackerel, sardines, herring, trout.
2. Omega-3 supplementation daily — 250 mg+ EPA+DHA from fish oil or algae oil.
3. LipidCell for the complementary squalane/ceramide/vitamin A/E angle if dryness or barrier issues are the main complaint.
4. Vitamin C daily for collagen formation.
5. Stay on the routine for at least 8–12 weeks before evaluating. Skin responds on that timescale, not weeks.

When skin issues need a dermatologist

• Persistent eczema, rosacea or acne that hasn't responded to basic care.
• Sudden severe skin changes, unexplained rashes.
• Any new mole or skin change that looks like a lesion.
• Chronic itchy skin with poor sleep impact.
• Skin issues in a child.

Specialist dermatology handles the medical conditions. Supplements sit alongside care, not instead of it.

In practice

Omega-3 EPA and DHA are one of the most evidence-backed inside-out inputs for skin quality, sitting at the centre of membrane lipid biology and inflammatory signalling. The dose target is 250 mg+ daily (authorised claim threshold), achievable from oily fish twice a week plus a well-chosen supplement. Paired with the authorised-claim skin nutrients — vitamins A, C, E, zinc, B-vitamins — and the structural ingredients in LipidCell and Hi!Collagen, the inside-out skin stack becomes a real tool rather than a marketing promise. Outside-in skincare handles the surface. Omega-3 handles the biology underneath it.

References

1. European Commission. EU Register of Nutrition and Health Claims Made on Foods. ec.europa.eu
2. Smith RN, Mann NJ, Braue A, Mäkeläinen H, Varigos GA. A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. Am J Clin Nutr. 2007;86(1):107–115. PubMed: 17616769
3. NHS. Fish and shellfish nutrition. nhs.uk
4. Dyerberg J, Madsen P, Møller JM, Aardestrup I, Schmidt EB. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids. 2010;83(3):137–141. PubMed: 20638827
5. Burdge GC, Wootton SA. Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr. 2002;88(4):411–420. PubMed: 12323090

---